Supplier to Physiotherapists, General Public, the NHS & Armed Forces

Clinical Lipidology: A Companion to Braunwald's Heart Disease. Edition: 2

Not rated yet
0
145   – Reward points

Clinical Lipidology, a companion to Braunwald's Heart Disease, is designed to guide you through the ever-changing therapeutic management of patients with high cholesterol levels. From basic science to pathogenesis of atherothrombotic disease, to risk assessment and the latest therapy options, this medical reference book offers unparalleled coverage and expert guidance on lipidology in a straightforward, accessible, and user-friendly style.

Availability: MD - Manufactured on demand
  • £145.94   incl. Vat 5% (£138.99 excl. Vat)
Qty:  
  • Shipping info

    Our publishing partner, Elsevier, maintains a flat fee for shipping. Books are delivered in the UK via DHL and will require a signature upon delivery.

    The standard delivery time within the UK is 2 working days from the date of invoice.

    Manufactured on demand titles take an extra 3-5 working days.

    At this time we only ship Elsevier book orders to addresses within the UK.

    Brexit: We have been informed that some couriers are now charging additional fees for importing from the UK into the EU. The customer is responsible for the payment of any import duties that are in addition to the shipping costs already charged.

  • Payment methods

    logos-payments-tab_1.png

Section 1 Basic Mechanisms

1. Human Plasma Lipoprotien Metabolism

2. Regulation and Clearance of Apolipoprotein B-Containing Lipoproteins

3. Absorption and Excretion of Intestinal Cholesterol and Other Sterols

4. High-Density Lipoprotein Metabolism

5. Lipoproteins: Mechanisms for Atherogenesis and Progression of Atherothrombotic Disease

6. Impact of Rare and Common Genetic Variants on Lipoprotein Metabolism

7. Lipoprotein Oxidation: Mechanisms and Biotheranostic Applications

Section 2 Risk Assessment

8. Cholesterol: Concentration, Ratio, and Particle Number

9. High-Density Lipoprotein Cholesterol and Triglycerides in Coronary Heart Disease Risk Assessment

10. Lipoprotein(a)

11. Clinical Evaluation for Genetic and Secondary Causes of Dyslipidemia

12. Use of High Sensitivity C-Reactive Protein for Risk Assessment

13. Role of Lipoprotein-Associated Phospholipase A2 in Vascular Disease

14. Emerging Assays

15. Imaging Atherosclerosis for Risk Stratification by Cardiac Computed Tomography or Carotid Ultrasound

Section 3 Therapy

16. Overview of General Approach to Management of Elevated Low-Density Lipoprotein Cholesterol and Mixed Dyslipidemia, High Triglycerides, and Low High-Density Lipoprotein Cholesterol

17. Treatment Guidelines Overview

18. Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease

19. Exercise and Lipids

20. Weight Loss

21. Statins

22. Bile Acid Sequestrants

23. Cholesterol Absorption Inhibitors

24. Niacin (Nicotinic Acid)

25. Fibrates

26. Omega-3 Fatty Acids

27. Combination Therapy for Dyslipidemia

28. Nutriceuticals and Functional Foods for Cholesterol Reduction

29. Evolving Targets of Therapy: Cholesteryl Ester Transfer Protein Inhibition

30. Evolving Targets of Therapy: Proprotein Convertase Subtilisin/Kexin 9 Inhibition

31. Evolving Targets of Therapy: Inflammation as a Method to Predict and Prevent Cardiovascular Events

32. Invasive Imaging Modalities and Atherosclerosis: Intravascular Ultrasound

33. Noninvasive Imaging Modalities and Atherosclerosis: The Role of Ultrasound

34. Noninvasive Imaging Modalities and Atherosclerosis: The Role of Magnetic Resonance Imaging and Positron Emission Tomography Imaging

35. Special Patient Populations: Diabetes and Metabolic Syndrome

36. Special Patient Populations: Women and Elderly

37. Special Patient Populations: Children and Adolescents

38. Special Patient Populations: Familial Hypercholesterolemia and other Severe Hypercholesterolemias

39. Special Patient Populations: Acute Coronary Syndromes

40. Special Patient Populations: Transplant Recipients

41. Special Patient Populations: Chronic Kidney Disease

42. Special Patient Populations: Lipid Abnormalities in High-Risk Ethnic Groups

43. Special Patient Populations: Human Immunodeficiency Patients

44. Therapeutic Targeting of High-Density Lipoprotein Metabolism

    • SKU
      9780323287869
    • UPC/ISBN
      9780323287869
    • Stock Last Checked
      Nov 26, 2021
  • Manufacturer
    Elsevier
  • Publication Date
    Dec 11, 2014
Customer reviews
There are no comments yet. Be the first to leave a comment
Please sign in to add review

Your Elsevier book orders are actioned within 48hrs during the working week. If any one item in your purchase is delayed we will send you what is in stock and will send on the remainder as soon as it arrives. This is provided at no additional shipping cost to you. Stock availability levels are updated on a daily basis.  We ship directly from a UK warehouse.

Shipping Costs

We currently maintain a flat fee structure for shipping book titles from Elsevier. Buy as many Elsevier titles as you like the we will still charge you the same single item shipping fee.

Overview Delivery Methods

Books are delivered in the UK via DHL and will require a signature upon delivery.

Deliveries within the UK

  • The standard delivery time within the UK is 2 working days from the date of invoice.
  • Print on demand titles take 3-5 working days.

Where is my order? Order Tracking

To find out more information about your order, select from the relevant options below:

Deliveries to the UK and UK shippers

Your order should be delivered to you/your shipper within 2-3 working days.

To track any deliveries using DPD, click here.

If your order is for a print on demand title, your delivery time will be longer, please allow an extra 3-5 working days.

We accept the following payment methods:

Elsevier maintains a standard returns policy